Delivery Order SPE2DB22D2206-SPE2DB24FJK93

Award Date 7/25/24
Potential Completion Date 8/15/24
Potential Value $8.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,139.33 firm fixed-price contract is for the delivery of 120 capsules of the drug Tafinlar 75 mg. The ultimate completion date for this order is April 17, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
The U.S. Defense Logistics Agency (DLA) awarded a $8,139.33 firm-fixed-price delivery order to AmerisourceBergen Drug Corporation for the supply of 4,565,810 units of the pharmaceutical product Tafinlar 75 mg capsules. The order has an ultimate completion date of October 4, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) valued up to $999,999,999 with the DLA Troop Support Medical through December 2025 for delivering a range...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $16,278.68, is for the supply of Tafinlar 75 mg capsules. It is a firm fixed-price delivery order contract with an ultimate completion date of August 28, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for...
The U.S. Defense Logistics Agency (DLA) awarded a $8,139.33 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 120 count capsules of the oncology medication TAFINLAR 75 mg. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical to provide a comprehensive range of medical commodities to support military treatment...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office Division. The $8,139.33 Firm Fixed Price delivery order is for the provision of 120 count bottles of the prescription drug Tafinlar 75 mg capsules. The award is not associated with a set-aside designation. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The contract is for the supply of Tafinlar 50 mg capsules, a prescription medication, with a ceiling value of $6,313.86 and an ultimate completion date of October 28, 2024. The contract is a firm-fixed-price delivery order, and there is no set-aside designation. As one of the largest pharmaceutical distributors in the United States,...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the medication TAFINLAR 75 MG CAPSULE 120S. The contract has a ceiling value of $8,896.41 and is a firm fixed-price delivery order with a completion date of June 9, 2025. The contract is not set-aside and was awarded on May 16, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,490.57, is for the delivery of 4559459167 TAFINLAR 75 MG CAPSULE 120S. This is a Delivery Order contract with a Firm Fixed Price pricing type. The contract has an ultimate completion date of January 19, 2023 and was awarded on December 27, 2022. The place of performance is Conshohocken, PA....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of TAFINLAR 75 MG CAPSULE 120S. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $8,139.33 and an ultimate completion date of November 5, 2024. Amerisourcebergen, through its Corporate Office division, will supply this medication to support military treatment facilities and other federal healthcare providers....
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, with a ceiling value of $8,139.33, is for the delivery of TAFINLAR 75 MG CAPSULE 120S, a type of prescription pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of October 9, 2024. This award is part of a larger Indefinite Delivery Contract...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB24FJK93
    Delivery Order

This is a $8,139.33 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 120 units of the cancer medication Tafinlar 75 mg capsules. The contract has an ultimate completion date of August 15, 2024 and does not have a set-aside designation. AmerisourceBergen holds significant Indefinite Delivery Contracts (IDCs) with DLA Troop Support Medical and the Department of Justice Federal Bureau of Investigation for providing a wide range of pharmaceutical and medical supplies to support federal healthcare programs and facilities. These IDCs, valued up to $999,999,999 and $750,000 respectively, serve as primary vehicles for AmerisourceBergen to efficiently deliver critical medical commodities to various government agencies and departments.

Generated 10/27/24, 4:31 AM